Copyright © 2012 Frederick T. Fraunfelder et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. B. D. Sullivan, D. Whitmer, K. K. Nichols et al., “An objective approach to dry eye disease severity,” Investigative Ophthalmology and Visual Science, vol. 51, no. 12, pp. 6125–6130, 2010. View at Publisher · View at Google Scholar · View at Scopus
2. K. K. Nichols, G. N. Foulks, A. J. Bron et al., “The international workshop on meibomian gland dysfunction: executive summary,” Investigative Ophthalmology and Visual Science, vol. 52, no. 4, pp. 1922–1929, 2011. View at Publisher · View at Google Scholar · View at Scopus
3. G. N. Foulks and A. J. Bron, “Meibomian gland dysfunction: a clinical scheme for description, diagnosis, classification, and grading,” The Ocular Surface, vol. 1, no. 3, pp. 107–126, 2003. View at Scopus
4. S. Zhou, Y. Li, A. T. H. Lu et al., “Reproducibility of tear meniscus measurement by Fourier-domain optical coherence tomography: a pilot study,” Ophthalmic Surgery Lasers and Imaging, vol. 40, no. 5, pp. 442–447, 2009. View at Publisher · View at Google Scholar · View at Scopus
5. P. L. Kaufman, A. Alm, and F. H. Adler, Adler’s Physiology of the Eye: Clinical Application, Mosby, St. Louis, Mo, USA, 10th edition, 2003.
6. B. K. B. Berkovitz, G. R. Holland, and B. J. Moxham, Oral Anatomy, Histology and Embryology, Mosby/Elsevier, New York, NY, USA, 4th edition, 2009.
7. L. M. Sreebny and S. S. Schwartz, “A reference guide to drugs and dry mouth—2nd edition,” Gerodontology, vol. 14, no. 1, pp. 33–47, 1997. View at Publisher · View at Google Scholar · View at Scopus
8. O. D. Schein, M. C. Hochberg, B. Muñoz et al., “Dry eye and dry mouth in the elderly: a population-based assessment,” Archives of Internal Medicine, vol. 159, no. 12, pp. 1359–1363, 1999. View at Publisher · View at Google Scholar · View at Scopus
9. J. Guggenheimer and P. A. Moore, “Xerostomia: etiology, recognition and treatment,” Journal of the American Dental Association, vol. 134, no. 1, pp. 61–69, 2003. View at Scopus
10. S. E. Moss, R. Klein, and B. E. K. Klein, “Long-term incidence of dry eye in an older population,” Optometry and Vision Science, vol. 85, no. 8, pp. 668–674, 2008. View at Publisher · View at Google Scholar · View at Scopus
11. S. E. Moss, R. Klein, and B. E. K. Klein, “Prevalance of and risk factors for dry eye syndrome,” Archives of Ophthalmology, vol. 118, no. 9, pp. 1264–1268, 2000. View at Scopus
12. D. A. Schaumberg, R. Dana, J. E. Buring, and D. A. Sullivan, “Prevalence of dry eye disease among US men: estimates from the Physicians' Health Studies,” Archives of Ophthalmology, vol. 127, no. 6, pp. 763–768, 2009. View at Publisher · View at Google Scholar · View at Scopus
13. F. T. Fraunfelder, F. W. Fraunfelder, and W. A. Chambers, Clinical Ocular Toxicology, Elsevier Saunders, 2008.
14. PDR Staff, Physicians’Desk Reference, PDR Network, LLC, Montvale, NJ, USA, 64th edition, 2010.
15. G. N. Foulks, “2007 Report of the international dry eye workshop (DEWS),” The Ocular Surface, vol. 5, no. 2, pp. 65–204, 2007. View at Scopus
16. S. L. Slabaugh, V. Maio, M. Templin, and S. Abouzaid, “Prevalence and risk of polypharmacy among the elderly in an outpatient setting: a retrospective cohort study in the Emilia-Romagna region, Italy,” Drugs & Aging, vol. 27, no. 12, pp. 1019–1028, 2010. View at Publisher · View at Google Scholar · View at Scopus
17. Q. Gu, C. F. Dillon, and V. L. Burt, “Prescription drug use continues to increase: US prescription drug data for 2007–2008,” NCHS Data Brief, no. 42, pp. 1–8, 2010. View at Scopus
18. F. T. Fraunfelder and J. H. Gilbaugh, Retire Right: 8 Scientifically Proven Traits You Need for a Happy, Fulfilling Retirement, Penguin, New York, NY, USA, 2008.
19. T. Osterberg, S. Landahl, and B. Hedegard, “Salivary flow, saliva, pH and buffering capacity in 70-year-old men and women. Correlation to dental health, dryness in the mouth, disease and drug treatment,” Journal of Oral Rehabilitation, vol. 11, no. 2, pp. 157–170, 1984. View at Scopus
20. W. J. Loesche, J. Bromberg, M. S. Terpenning et al., “Xerostomia, xerogenic medications and food avoidances in selected geriatric groups,” Journal of the American Geriatrics Society, vol. 43, no. 4, pp. 401–407, 1995. View at Scopus
21. R. E. Persson, K. T. Izutsu, E. L. Truelove, and R. Persson, “Differences in salivary flow rates in elderly subjects using xerostomatic medications,” Oral Surgery, Oral Medicine, Oral Pathology, vol. 72, no. 1, pp. 42–46, 1991. View at Scopus
22. L. M. Sreebny, A. Valdini, and A. Yu, “Xerostomia. Part II: relationship to nonoral symptoms, drugs, and diseases,” Oral Surgery, Oral Medicine, Oral Pathology, vol. 68, no. 4 I, pp. 419–427, 1989. View at Scopus
23. J. J. Rybacki and J. W. Long, The Essential Guide To Prescription Drugs, Harper Perennial, New York, NY, USA, 1996.
24. I. R. Edwards and C. Biriell, “Harmonisation in pharmacovigilance,” Drug Safety, vol. 10, no. 2, pp. 93–102, 1994. View at Scopus
25. R. D. Fechtner, D. G. Godfrey, D. Budenz, J. A. Stewart, W. C. Stewart, and M. C. Jasek, “Prevalence of ocular surface complaints in patients with glaucoma using topical intraocular pressure-lowering medications,” Cornea, vol. 29, no. 6, pp. 618–621, 2010. View at Publisher · View at Google Scholar · View at Scopus
26. G. C. M. Rossi, C. Tinelli, G. M. Pasinetti, G. Milano, and P. E. Bianchi, “Dry eye syndrome-related quality of life in glaucoma patients,” European Journal of Ophthalmology, vol. 19, no. 4, pp. 572–579, 2009. View at Scopus
27. S. C. Pflugfelder, “Antiinflammatory therapy for dry eye,” American Journal of Ophthalmology, vol. 137, no. 2, pp. 337–342, 2004. View at Publisher · View at Google Scholar · View at Scopus
28. C. Baudouin, C. Garcher, N. Haouat, A. Bron, and P. Gastaud, “Expression of inflammatory membrane markers by conjunctival cells in chronically treated patients with glaucoma,” Ophthalmology, vol. 101, no. 3, pp. 454–460, 1994. View at Scopus
29. C. Baudouin, H. Liang, P. Hamard et al., “The ocular surface of glaucoma patients treated over the long term expresses inflammatory markers related to both T-helper 1 and T-helper 2 pathways,” Ophthalmology, vol. 115, no. 1, pp. 109–115, 2008. View at Publisher · View at Google Scholar · View at Scopus
30. E. Viso, F. Gude, and M. T. Rodríguez-Ares, “The association of meibomian gland dysfunction and other common ocular diseases with dry eye: a population-based study in Spain,” Cornea, vol. 30, no. 1, pp. 1–6, 2011. View at Publisher · View at Google Scholar · View at Scopus
31. E. M. Hay, E. Thomas, B. Pal, A. Hajeer, H. Chambers, and A. J. Silman, “Weak association between subjective symptoms of and objective testing for dry eyes and dry mouth: results from a population based study,” Annals of the Rheumatic Diseases, vol. 57, no. 1, pp. 20–24, 1998. View at Scopus
32. O. D. Schein, M. C. Hochberg, B. Muñoz et al., “Dry eye and dry mouth in the elderly: a population-based assessment,” Archives of Internal Medicine, vol. 159, no. 12, pp. 1359–1363, 1999. View at Publisher · View at Google Scholar · View at Scopus
33. E. W. Leung, F. A. Medeiros, and R. N. Weinreb, “Prevalence of ocular surface disease in glaucoma patients,” Journal of Glaucoma, vol. 17, no. 5, pp. 350–355, 2008. View at Publisher · View at Google Scholar · View at Scopus
34. R. L. Fellman, E. K. Sullivan, M. Ratliff et al., “Comparison of travoprost 0.0015% and 0.004% with timolol 0.5% in patients with elevated intraocular pressure: a 6-month, masked, multicenter trial,” Ophthalmology, vol. 109, no. 5, pp. 998–1008, 2002. View at Publisher · View at Google Scholar · View at Scopus
35. J. S. Cohen, R. L. Gross, J. K. Cheetham, A. M. VanDenburgh, P. Bernstein, and S. M. Whitcup, “Two-year double-masked comparison of bimatoprost with timolol in patients with glaucoma or ocular hypertension,” Survey of Ophthalmology, vol. 49, no. 2, supplement 1, pp. S45–S52, 2004. View at Publisher · View at Google Scholar · View at Scopus
36. A. Alm, C. B. Camras, and P. G. Watson, “Phase III latanoprost studies in Scandinavia, the United Kingdom and the United States,” Survey of Ophthalmology, vol. 41, supplement 2, pp. S105–S110, 1997. View at Scopus
37. C. Baudouin, A. Labbé, H. Liang, A. Pauly, and F. Brignole-Baudouin, “Preservatives in eyedrops: the good, the bad and the ugly,” Progress in Retinal and Eye Research, vol. 29, no. 4, pp. 312–334, 2010. View at Publisher · View at Google Scholar · View at Scopus
38. N. Jaenen, C. Baudouin, P. Pouliquen, G. Manni, A. Figueiredo, and T. Zeyen, “Ocular symptoms and signs with preserved and preservative-free glaucoma medications,” European Journal of Ophthalmology, vol. 17, no. 3, pp. 341–349, 2007. View at Scopus
39. D. C. Broadway, I. Grierson, C. O'Brien, and R. A. Hitchings, “Adverse effects of topical antiglaucoma medication. II. The outcome of filtration surgery,” Archives of Ophthalmology, vol. 112, no. 11, pp. 1446–1454, 1994. View at Scopus
40. M. B. Kashkouli, R. Rezaee, N. Nilforoushan, S. Salimi, A. Foroutan, and M. Naseripour, “Topical antiglaucoma medications and lacrimal drainage system obstruction,” Ophthalmic Plastic and Reconstructive Surgery, vol. 24, no. 3, pp. 172–175, 2008. View at Publisher · View at Google Scholar · View at Scopus
41. N. Seider, B. Miller, and I. Beiran, “Topical glaucoma therapy as a risk factor for nasolacrimal duct obstruction,” American Journal of Ophthalmology, vol. 145, no. 1, pp. 120–123, 2008. View at Publisher · View at Google Scholar · View at Scopus
42. I. R. Schwab, J. V. Linberg, V. M. Gioia, W. H. Benson, and G. M. Chao, “Foreshortening of the inferior conjunctival fornix associated with chronic glaucoma medications,” Ophthalmology, vol. 99, no. 2, pp. 197–202, 1992. View at Scopus
43. J. E. Thorne, G. J. Anhalt, and D. A. Jabs, “Mucous membrane pemphigoid and pseudopemphigoid,” Ophthalmology, vol. 111, no. 1, pp. 45–52, 2004. View at Publisher · View at Google Scholar · View at Scopus